NCT03699930View on ClinicalTrials.gov

Impact of Neuromodulation on Language Impairments in Stroke Patients

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

September 1, 2022

Study Completion Date

January 1, 2023

Conditions
StrokeAphasia
Interventions
DEVICE

tDCS

Anodal or sham tDCS will be applied to the scalp.

BEHAVIORAL

Speech and language therapy

A trained speech pathologist will administer the speech and language therapy.

Trial Locations (1)

91769

Casa Colina Hospital and Centers for Healthcare, Pomona

All Listed Sponsors
lead

Casa Colina Hospital and Centers for Healthcare

OTHER

NCT03699930 - Impact of Neuromodulation on Language Impairments in Stroke Patients | Biotech Hunter | Biotech Hunter